Not Losing Much Weight on Wegovy — What's Really Going On

Is slow weight loss on Wegovy normal in the first few months?

Yes, and it's probably the single biggest source of anxiety our prescribers hear about from patients in the early weeks. The expectation many people carry into treatment (that the appetite suppression will be dramatic and immediate) isn't quite what the clinical data shows. In the STEP 1 trial, published in the New England Journal of Medicine, participants lost an average of around 15% of their starting body weight, but that happened across 68 weeks, with the steepest loss concentrated in the middle phase of treatment, not at the start.

There's a common misconception worth letting go of here: that if you haven't lost a noticeable amount in the first four to six weeks, something has gone wrong. The 0.25mg starting dose isn't designed to produce weight loss. Its job is to let your system adjust to the medicine before the dose rises. Most people notice appetite changes becoming more meaningful somewhere between the 1mg and 2.4mg stages of titration. If you're still on a lower dose, the honest answer is that the medicine may not yet be at the level where it's most effective for you.

If you want a clearer sense of the expected timeline, our guide to how long Wegovy takes to work covers what to expect at each stage of the titration journey.

Why might weight loss stall even at the full dose?

Plateaus are one of the most reliably documented features of GLP-1 treatment, and they don't signal that the medicine has stopped working. What's happening physiologically is that the body responds to weight loss by reducing its resting metabolic rate, it becomes more efficient, essentially resisting further loss. This is a biological protection mechanism, not a character flaw, and it affects most people regardless of what approach they use to lose weight.

Several practical factors can also blunt Wegovy's effect even at 2.4mg. Inadequate protein intake is one of the most common: when appetite falls sharply, many people eat less overall but also eat less protein, which accelerates muscle loss and slows metabolism further. Disrupted sleep, high chronic stress (which raises cortisol), and low physical activity all work against the medicine's effects in ways that are genuinely meaningful at a population level. The NHS patient information on semaglutide notes that Wegovy is intended to be used alongside a reduced-calorie diet and increased physical activity, the medicine works within that framework, not instead of it.

There's also individual biological variation in how people absorb and respond to semaglutide. Some people are slower responders who see their main results after six months rather than three. If you're worried you might be in a different situation entirely, our page on not losing weight on semaglutide explores the broader picture across different doses and circumstances.

When does slow progress become something worth raising with your prescriber?

NICE's guidance on semaglutide for weight management (TA875) includes a review point: if someone hasn't lost at least 5% of their starting body weight after six months at the maintenance dose, continuing treatment should be clinically reassessed. That's a formal threshold, not an arbitrary number. It's also worth knowing that this assessment is meant to happen with a prescriber, not based on a six-week weigh-in at a lower dose.

Signs that a conversation with your prescriber is genuinely warranted include: no measurable weight change over eight to twelve weeks at the same dose, significant side effects that are preventing you from eating adequately, or any new health changes since starting treatment. If you're considering adjusting your dose, timing or anything else about your regimen, that decision belongs with the clinician who reviewed your case, not with online guidance, however well-intentioned.

For a more detailed look at the specific question of seeing no change at all, our page on not losing any weight on Wegovy goes deeper into when that warrants urgent review versus watchful patience. And if you're thinking about whether your current treatment is still the right fit, our weight-loss treatment overview sets out the full range of licensed options available through a private prescription.

What can you actually do while waiting for results to improve?

The practical steps that make the most consistent difference are the ones that complement what Wegovy is already doing: keeping protein intake adequate (aiming for it at every meal, even when appetite is low), staying hydrated, maintaining some form of resistance or weight-bearing activity to preserve muscle mass, and getting enough sleep. None of these are revolutionary, but on GLP-1 treatment they carry more weight than they might otherwise, because the medicine is already handling one piece of the puzzle.

Alcohol is worth mentioning specifically. Calorie-dense drinks can offset a significant portion of the deficit the medicine creates, and tolerance to alcohol often changes during GLP-1 treatment, something prescribers flag regularly. The NHS England guidance on weight-management injections emphasises lifestyle support as a core component of treatment, not an optional extra. If you are on Wegovy but not losing weight despite addressing these factors, it may be worth looking at whether the dose, timing or supporting behaviours need reviewing with your prescriber. Readers who want to dig into the detail of why they are not losing weight on Wegovy will find a thorough breakdown of the most common physiological and practical reasons progress can stall. And if your results have been disappointing and you're asking yourself why you're not losing weight on Wegovy, that guide walks through a structured way to assess what might need to change.

If you're finding that progress has genuinely stalled and you've addressed the lifestyle factors, speaking to a prescriber is the right move. A clinical review through our free consultation gives you access to a GPhC-registered prescriber who can review your situation properly and advise on next steps. It's worth the conversation.